Skip navigation.

Welcome to SAfAIDS

SAfAIDS news

Press release: International Women’s Day celebrations champion a Planet 50-50 by 2030

NEW YORK, 7 March 2016 (UNWOMEN)  -  International Women’s Day celebrations on 8 March will mobilize people around the world to call for a Planet 50-50 by 2030. UN Women is organizing a series of diverse, high-profile events in over 40 countries, where ordinary citizens, activists, musicians, athletes, students, security personnel, scholars and stock exchange officials will be among those who commit to “Stepping It Up for Gender Equality.”

Expanding treatment and PrEP could prevent 185,000 new HIV infections, US CDC says

BOSTON, 02 March 2016 (Aidsmap)- Increasing diagnosis, care and treatment of people living with HIV could lead to a large decrease in HIV incidence, preventing some 168,000 new infections by the year 2020, according to a new US Centers for Disease Control and Prevention (CDC) analysis presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) last week in Boston. The impact of pre-exposure prophylaxis (PrEP) would be comparatively modest, but its importance would be greater if more people with HIV are not on treatment with undetectable viral load.

Rate of entry into HIV care improved by personalised counselling

BOSTON, 01 March 2016 (Aidsmap)- Entry into HIV care can be increased by around 40% if people receive a point-of-care CD4 test and counselling sessions to overcome personal barriers to seeking HIV care, a large randomised study in South Africa has shown. However, the study also found that only half of the people who received the most effective linkage intervention and who were in need of immediate treatment made it onto treatment within six months of their HIV diagnosis, highlighting the need for further improvements in linkage to HIV care.

Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy

BOSTON, 01 March 2016 (Aidsmap)- Engaging lay counsellors to provide a combination package of evidence-based interventions in Nyanza, Kenya and addressing partner disclosure, as well as pre-treatment education about the benefits of antiretroviral therapy (ART) for maternal and child health in Malawi’s Option B+ programme, improved retention in care and reduced loss to follow-up of mothers with HIV and their infants, studies presented last week at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston show.

Option B+ has enabled Malawi to make significant progress towards 90-90-90

BOSTON, 27 February 2016 (Aidsmap)-  In four years, Malawi’s treatment cascade for pregnant women has been transformed so that the proportion of women with HIV who are diagnosed has gone from 49 to 80%, and the proportion who are virally suppressed has jumped from 2 to 48%, the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston heard this week.

Dapivirine vaginal ring helped protect women against HIV in ASPIRE Phase III trial

BOSTON, 22 February 2016 (sciencedaily) - A vaginal ring containing an antiretroviral (ARV) drug called dapivirine that women use for a month at a time was safe and helped protect against HIV in a large-scale clinical trial involving more than 2,600 women in Africa, researchers who conducted the trial, known as ASPIRE, reported.

Syndicate content